Marketing of Unproven and Unapproved Regenerative Medicine Therapies

Abstract

Get full access to this article

View all access options for this article.

References

Eliasberg

Nemirov

Mandelbaum

, et al. Complications following biologic therapeutic injections: a multicenter case series. Arthroscopy. 2021;37(8):2600-2605.

Ikonomou

Cuende

Forte

, et al. International Society for Cell & Gene Therapy Position Paper: key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products. Cytotherapy. 2023;25(9):920-929.

Master

Matthews

KRW

Abou-El-Enein

. Unproven stem cell interventions: a global public health problem requiring global deliberation. Stem Cell Reports. 2021;16(6):1435-1445.

MedWatch: the FDA safety information and adverse event reporting program. US Food and Drug Administration. https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program. Accessed January 22, 2024.